Government News

Health Ministry : Now Clinical Trials will be evaluated on parameters given by Supreme Court

  • Posted on: 12 September 2014
  • By: PharmaTutor News

(12th September, 2014); Now in India, all the Global Clinical Trials (GCTs)/New Clinical Trials (NCEs) should be evaluated on regard to parameters given by Honorable supreme court. Drugs controller general of India (DCGI) clearly mentioned on all parameters in their notice.

CDSCO implement uniform regulatory procedures for COPP & GMP inspections

  • Posted on: 6 August 2014
  • By: PharmaTutor News

(6th August, 2014); Central Drugs Standard Control Organization (CDSCO) ensuring uniform procedures in regulatory inspection for issuance of Certificates of Pharmaceutical Products (COPP) and other Good Manufacturing Practices (GMP) inspections. These procedures were discussed in 47th Drugs consultative committee (DCC) meeting.

Significant finding by ICMR on radiations emitted from mobile phone and mobile phone tower

  • Posted on: 6 August 2014
  • By: PharmaTutor News

(6th August, 2014); Indian Council of Medical Research (ICMR) have initiated a multi-disciplinary cohort study in Delhi and national capital region to find out adverse effects of Radio Frequency Radiation (RFR), if any, emitted from cell phone on adult Indian population.

Government's Task Force recommends ways to tackle anti-microbial resistance

  • Posted on: 5 August 2014
  • By: PharmaTutor News

(5th August, 2014); It is known that data related to antibiotics consumption is not maintained in India. And truly it is hard to obtain such data when everything is mess up around. But it is of utmost importance to capitalize such data to fight with microbial resistance. The concern is growing for antimicrobial resistance in pathogens on account of increased availability and use of antibiotics across the country meant for human, animal and industrial consumption.

India stepping ahead with a plan of creating IT enabled Clinical Research Monitoring

  • Posted on: 29 July 2014
  • By: PharmaTutor News

(29th July, 2014); Looking at the current regulatory environment of clinical trial in India, it is important that all information related to 4 major domains i.e, Sponsor/ CRO, Investigator, Ethics Committee, Patient of clinical trials are captured through online in an organized manner. Hence, for ensuring transparency and faster dissemination of information about clinical trials, health ministry may start information technology (IT) enabled platform. The recommendation of such platform is provided by Prof. Ranjit Roy Chaudhary Committee.

PCI disapproved MS Pharmacy courses from any institutions except from NIPERs

  • Posted on: 24 July 2014
  • By: PharmaTutor News

(24th July, 2014); Pharmacy Council of India (PCI) announced in its notification that MS Programmes are not approved by the PCI either for the purpose of registration as a pharmacist under the Pharmacy Act to practice the profession OR any other purpose like teaching in approved pharmacy institutions.

Deliberations and recommendations made by the Apex Committee for supervising clinical trials

  • Posted on: 9 July 2014
  • By: PharmaTutor News

(9th July, 2014); The meeting of the apex committee held on 17-06-2014 under the chairmanship secretary  of health and family welfare for supervising clinical trials (CTs) on new chemical entities in the light of directions of the honorable supreme court of India dated 03.01.2013

Pages